newsfilter
← Latest News
Business Wire·

Revance to Participate in Upcoming Investor Conferences

Revance Therapeutics, Inc. (RVNC), today announced that the company will be participating in the following investor conferences. Stifel 2023 Healthcare Conference Chief Financial Officer, Tobin Schilke, is scheduled